Mengzhao Zhang

882 citations
41 papers · 579 indexed · h-index 14
Topics
Ferroptosis and cancer prognosis (6 papers)Bladder and Urothelial Cancer Treatments (6 papers)Epigenetics and DNA Methylation (5 papers)
Partner nations
ChinaUnited States

In The Last Decade

Mengzhao Zhang

37 papers receiving 569 citations

Peers

Mengzhao Zhang
Comparison fields: 5 of 92
  • Molecular Biology 254
  • Cancer Research 125
  • Oncology 108
  • Pulmonary and Respiratory Medicine 92
  • Surgery 77
Replace Shanling Xu with:
Shanling Xu China
Fanni Li China
Hongxu Liu China
Juyong Wang China
Rui Xin China
Zejia Yang United States
Moon‐Taek Park South Korea
Camila Maria Longo Machado Brazil
Vicenç Ruiz de Porras Spain
Jincheng Yang China
Mengzhao Zhang relative to Shanling Xu China Shanling Xu's profile →
Citations per field
00.5×3.3×
Shanling Xu · 1×
Citations per year

Countries citing papers authored by Mengzhao Zhang

Since Specialization
Citations

This map shows the geographic impact of Mengzhao Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengzhao Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengzhao Zhang more than expected).

Fields of papers citing papers by Mengzhao Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mengzhao Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengzhao Zhang. The network helps show where Mengzhao Zhang may publish in the future.

Co-authorship network of co-authors of Mengzhao Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Mengzhao Zhang. A scholar is included among the top collaborators of Mengzhao Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mengzhao Zhang. Mengzhao Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 3
4 1
5 2
6 11
7 6
8 3
9 19
10 6
11 4
12 18
13 13
14 4
15 3
16 12
17 22
18 10
19 76
20 28

About Mengzhao Zhang

Mengzhao Zhang is a scholar working on Biochemistry, Geochemistry and Petrology and Cancer Research, having authored 41 papers that have together received 579 indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (6 papers), Bladder and Urothelial Cancer Treatments (6 papers) and Epigenetics and DNA Methylation (5 papers). The work is most often cited by research in Toxicology (49 citations), Cancer Research (125 citations) and Complementary and alternative medicine (66 citations). Mengzhao Zhang has collaborated with scholars based in China and United States. Frequent co-authors include Jinhai Fan, Yangyang Yue, Weiyi Wang, Xinyang Wang, Pu Zhang, Minghai Ma, Jianbin Ma, Jin Zeng, Chengyun Wang and Zhixin Huang. Their work appears in journals such as Analytical Chemistry, Chemical Engineering Journal and The FASEB Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026